(Q36635588)

15 August 2017

1 reference

title

The biological basis for clinical use of interferon (English)

1 reference

Maria Rosaria Capobianchi

15 August 2017

3

object named as

M. R. Capobianchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706739

3 November 2022

author name string

F. Dianzani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706739

3 November 2022

G. Antonelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706739

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1706739

3 November 2022

publication date

1 January 1990

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:016882789090156L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

https://api.elsevier.com/content/article/PII:016882789090156L?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

3 November 2022

published in

Journal of Hepatology

1 reference

15 August 2017

11 Suppl 1

1 reference

15 August 2017

S5-10

1 reference

The human interferons—From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyond

15 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Mechanism of induction of gamma interferon

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Unexpectedly rapid action of human interferon in physiological conditions

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Biochemistry of Interferons and Their Actions

3 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus

3 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts

3 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons

3 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

The enhancing effect of interferon-beta and -gamma on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Antitumor action of interferon: animal systems

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Enhancement of human neonatal natural killer cytotoxicity to herpes simplex virus with use of recombinant human interferons: lack of neonatal response to gamma interferon

3 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease

3 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

3 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Circulating interferon in man after administration of exogenous human leukocyte interferon

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2

3 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Neurological effects of recombinant human interferon

3 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.

3 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Neurological effects of recombinant human interferon.

3 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

3 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

3 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0168-8278(90)90156-L

3 November 2022

Identifiers

1 reference

15 August 2017

1 reference